US Stock MarketDetailed Quotes

FGEN FibroGen

Watchlist
  • 0.348
  • -0.003-0.94%
Trading Dec 12 12:30 ET
35.04MMarket Cap-0.28P/E (TTM)

FibroGen Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
15.45%46.33M
14.26%50.64M
54.59%55.9M
4.99%147.75M
-21.03%27.14M
155.06%40.13M
48.69%44.32M
-40.55%36.16M
-40.19%140.73M
107.74%34.37M
Operating revenue
4.85%58.17M
-16.50%54.4M
47.93%72.59M
4.99%147.75M
-863.18%-21.95M
67.95%55.48M
71.05%65.14M
-26.47%49.07M
-40.19%140.73M
108.34%2.88M
Cost of revenue
24.79%5.3M
-9.29%5.18M
637.70%25.75M
-7.06%18.85M
9.79%5.41M
-1.51%4.24M
-16.17%5.71M
-17.63%3.49M
57.56%20.28M
57.60%4.93M
Gross profit
14.34%41.04M
17.75%45.46M
-7.72%30.15M
7.02%128.9M
-26.19%21.73M
214.09%35.89M
67.90%38.61M
-42.27%32.67M
-45.85%120.45M
119.42%29.44M
Operating expense
-54.75%39.26M
-55.49%56.38M
-43.72%61.21M
-5.54%398.11M
-20.57%75.93M
-17.43%86.77M
25.13%126.66M
-9.05%108.76M
-17.51%421.48M
-35.70%95.59M
Selling and administrative expenses
-31.36%17.55M
-28.56%22.28M
-33.42%22.82M
-7.57%115.25M
-28.68%24.22M
-14.48%25.57M
3.05%31.18M
12.14%34.28M
0.62%124.69M
-2.23%33.97M
Research and development costs
-64.53%21.71M
-64.28%34.11M
-48.46%38.39M
-4.69%282.86M
-16.10%51.7M
-18.61%61.19M
34.55%95.48M
-16.32%74.49M
-23.32%296.79M
-45.90%61.63M
Operating profit
103.49%1.78M
87.60%-10.92M
59.18%-31.06M
10.57%-269.21M
18.08%-54.2M
45.68%-50.88M
-12.56%-88.05M
-20.79%-76.09M
-4.33%-301.03M
51.09%-66.15M
Net non-operating interest income expense
-64.19%-1.19M
-1,354.20%-6.06M
-81.59%-2.43M
-182.07%-5.05M
-1,218.97%-2.57M
-142.36%-726K
-108.24%-417K
-218.85%-1.34M
385.93%6.16M
-120.92%-195K
Non-operating interest income
-11.50%3.8M
----
148.07%2.57M
37.97%10.48M
170.13%2.5M
138.93%4.3M
-48.99%2.65M
--1.04M
--7.6M
--924K
Non-operating interest expense
-0.56%4.99M
97.59%6.06M
110.62%5M
978.61%15.53M
352.90%5.07M
5,878.57%5.02M
2,076.60%3.07M
466.11%2.37M
-33.12%1.44M
220.06%1.12M
Other net income (expense)
-47.18%-18.55M
-12.61M
0
-12.61M
Special income (charges)
-47.18%-18.55M
----
----
---12.61M
--0
---12.61M
----
----
--0
--0
-Less:Restructuring and merger&acquisition
47.18%18.55M
----
----
--12.61M
--0
--12.61M
----
----
--0
--0
Income before tax
72.01%-17.97M
80.80%-16.98M
56.75%-33.49M
2.71%-286.87M
14.44%-56.77M
30.17%-64.21M
-20.91%-88.47M
-22.10%-77.43M
-1.44%-294.87M
50.60%-66.35M
Income tax
-85.71%12K
-11.49%-262K
-55.41%33K
-99.16%3K
-25.93%80K
-26.32%84K
-1,121.74%-235K
-34.51%74K
3.17%358K
-3.57%108K
Earnings from equity interest net of tax
32.64%898K
114.00%1.18M
-26.01%589K
67.71%2.64M
119.64%615K
66.34%677K
-2.65%550K
148.75%796K
56.21%1.57M
-18.37%280K
Net income
73.14%-17.08M
82.27%-15.54M
57.07%-32.93M
3.21%-284.23M
15.03%-56.23M
30.59%-63.62M
-20.73%-87.68M
-21.36%-76.71M
-1.25%-293.65M
50.64%-66.18M
Net income continuous Operations
73.14%-17.08M
82.27%-15.54M
57.07%-32.93M
3.21%-284.23M
15.03%-56.23M
30.59%-63.62M
-20.73%-87.68M
-21.36%-76.71M
-1.25%-293.65M
50.64%-66.18M
Minority interest income
Net income attributable to the parent company
73.14%-17.08M
82.27%-15.54M
57.07%-32.93M
3.21%-284.23M
15.03%-56.23M
30.59%-63.62M
-20.73%-87.68M
-21.36%-76.71M
-1.25%-293.65M
50.64%-66.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
73.14%-17.08M
82.27%-15.54M
57.07%-32.93M
3.21%-284.23M
15.03%-56.23M
30.59%-63.62M
-20.73%-87.68M
-21.36%-76.71M
-1.25%-293.65M
50.64%-66.18M
Basic earnings per share
73.85%-0.17
82.22%-0.16
59.26%-0.33
7.01%-2.92
18.57%-0.57
33.67%-0.65
-15.38%-0.9
-19.12%-0.81
0.00%-3.14
51.72%-0.7
Diluted earnings per share
73.85%-0.17
82.22%-0.16
59.26%-0.33
7.01%-2.92
18.57%-0.57
33.67%-0.65
-15.38%-0.9
-19.12%-0.81
0.00%-3.14
51.72%-0.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 15.45%46.33M14.26%50.64M54.59%55.9M4.99%147.75M-21.03%27.14M155.06%40.13M48.69%44.32M-40.55%36.16M-40.19%140.73M107.74%34.37M
Operating revenue 4.85%58.17M-16.50%54.4M47.93%72.59M4.99%147.75M-863.18%-21.95M67.95%55.48M71.05%65.14M-26.47%49.07M-40.19%140.73M108.34%2.88M
Cost of revenue 24.79%5.3M-9.29%5.18M637.70%25.75M-7.06%18.85M9.79%5.41M-1.51%4.24M-16.17%5.71M-17.63%3.49M57.56%20.28M57.60%4.93M
Gross profit 14.34%41.04M17.75%45.46M-7.72%30.15M7.02%128.9M-26.19%21.73M214.09%35.89M67.90%38.61M-42.27%32.67M-45.85%120.45M119.42%29.44M
Operating expense -54.75%39.26M-55.49%56.38M-43.72%61.21M-5.54%398.11M-20.57%75.93M-17.43%86.77M25.13%126.66M-9.05%108.76M-17.51%421.48M-35.70%95.59M
Selling and administrative expenses -31.36%17.55M-28.56%22.28M-33.42%22.82M-7.57%115.25M-28.68%24.22M-14.48%25.57M3.05%31.18M12.14%34.28M0.62%124.69M-2.23%33.97M
Research and development costs -64.53%21.71M-64.28%34.11M-48.46%38.39M-4.69%282.86M-16.10%51.7M-18.61%61.19M34.55%95.48M-16.32%74.49M-23.32%296.79M-45.90%61.63M
Operating profit 103.49%1.78M87.60%-10.92M59.18%-31.06M10.57%-269.21M18.08%-54.2M45.68%-50.88M-12.56%-88.05M-20.79%-76.09M-4.33%-301.03M51.09%-66.15M
Net non-operating interest income expense -64.19%-1.19M-1,354.20%-6.06M-81.59%-2.43M-182.07%-5.05M-1,218.97%-2.57M-142.36%-726K-108.24%-417K-218.85%-1.34M385.93%6.16M-120.92%-195K
Non-operating interest income -11.50%3.8M----148.07%2.57M37.97%10.48M170.13%2.5M138.93%4.3M-48.99%2.65M--1.04M--7.6M--924K
Non-operating interest expense -0.56%4.99M97.59%6.06M110.62%5M978.61%15.53M352.90%5.07M5,878.57%5.02M2,076.60%3.07M466.11%2.37M-33.12%1.44M220.06%1.12M
Other net income (expense) -47.18%-18.55M-12.61M0-12.61M
Special income (charges) -47.18%-18.55M-----------12.61M--0---12.61M----------0--0
-Less:Restructuring and merger&acquisition 47.18%18.55M----------12.61M--0--12.61M----------0--0
Income before tax 72.01%-17.97M80.80%-16.98M56.75%-33.49M2.71%-286.87M14.44%-56.77M30.17%-64.21M-20.91%-88.47M-22.10%-77.43M-1.44%-294.87M50.60%-66.35M
Income tax -85.71%12K-11.49%-262K-55.41%33K-99.16%3K-25.93%80K-26.32%84K-1,121.74%-235K-34.51%74K3.17%358K-3.57%108K
Earnings from equity interest net of tax 32.64%898K114.00%1.18M-26.01%589K67.71%2.64M119.64%615K66.34%677K-2.65%550K148.75%796K56.21%1.57M-18.37%280K
Net income 73.14%-17.08M82.27%-15.54M57.07%-32.93M3.21%-284.23M15.03%-56.23M30.59%-63.62M-20.73%-87.68M-21.36%-76.71M-1.25%-293.65M50.64%-66.18M
Net income continuous Operations 73.14%-17.08M82.27%-15.54M57.07%-32.93M3.21%-284.23M15.03%-56.23M30.59%-63.62M-20.73%-87.68M-21.36%-76.71M-1.25%-293.65M50.64%-66.18M
Minority interest income
Net income attributable to the parent company 73.14%-17.08M82.27%-15.54M57.07%-32.93M3.21%-284.23M15.03%-56.23M30.59%-63.62M-20.73%-87.68M-21.36%-76.71M-1.25%-293.65M50.64%-66.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 73.14%-17.08M82.27%-15.54M57.07%-32.93M3.21%-284.23M15.03%-56.23M30.59%-63.62M-20.73%-87.68M-21.36%-76.71M-1.25%-293.65M50.64%-66.18M
Basic earnings per share 73.85%-0.1782.22%-0.1659.26%-0.337.01%-2.9218.57%-0.5733.67%-0.65-15.38%-0.9-19.12%-0.810.00%-3.1451.72%-0.7
Diluted earnings per share 73.85%-0.1782.22%-0.1659.26%-0.337.01%-2.9218.57%-0.5733.67%-0.65-15.38%-0.9-19.12%-0.810.00%-3.1451.72%-0.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.